This inventor holds 139 USPTO granted patents and 72 published patent applications, plus 6 CIPO patents and 141 EPO patents, primarily in Communication Technology (CPC class H04L5-0048). Top assignees: Huawei Technologies Co., Limited, Tencent Technology (Shenzhen) Company Limited, Chinese Academy of Sciences. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Hong Kong, CN (2019 - 2022)
- Chengdu, CN (2014 - 2023)
- Guangdong, CN (2016 - 2023)
- Xi'an, CN (2023)
- Shenzhen, CN (2015 - 2024)
- Dongguan, CN (2019 - 2024)
- Hefei, CN (2024)
Company Filing History:
101 out of 30,003 
12 out of 5,429 
4 out of 3,370 
Years Active: 2014-2026
Areas of Expertise:
Title: Lei Chen: Innovating in Pharmaceutical Chemistry
Introduction:
Lei Chen, based in Dongguan, China, has established himself as an inventive force in the field of pharmaceutical chemistry. With a passion for developing new materials and innovative processes, he has made significant contributions to his industry. Working at Sunshine Lake Pharma Co., Ltd., Chen has consistently created groundbreaking solutions and holds two patents for his recent discoveries. This article will delve into his latest patents, career highlights, and collaborations, shedding light on his exceptional contributions to the field of pharmaceutical research and development.
Latest Patents:
Lei Chen's latest patents showcase his expertise and novel approaches in the field of pharmaceutical chemistry. His most recent patents include the invention of a sacubitril intermediate and its preparation method. This intermediate serves as a crucial component in the synthesis of sacubitril, a valuable compound used in the pharmaceutical industry. The method developed by Chen offers several advantages, including easy accessibility to raw materials, a simple preparation process, cost-effectiveness, and environmental friendliness. These patents highlight Chen's ability to create practical solutions with significant potential in industrial production.
Career Highlights:
Lei Chen's career is marked by his dedication to advancing pharmaceutical chemistry. His work at Sunshine Lake Pharma Co., Ltd. has been instrumental in driving innovation within the company. Through his tireless efforts, Chen has not only obtained patents but has also contributed to the development and commercialization of new pharmaceutical products. His accomplishments are a testament to his deep knowledge and expertise in the field.
Collaborations:
Successful innovation often stems from collaboration, and Lei Chen recognizes the value of working with peers to create breakthroughs. Notable among his collaborations are his colleagues Guodong Sun and Xiaodong Han. Working together, they have shared their expertise and insights to tackle complex challenges and develop novel solutions. These collaborations showcase Chen's ability to foster teamwork and bring together talented individuals from diverse backgrounds for greater innovation.
Conclusion:
Lei Chen's passion for pharmaceutical chemistry has driven him to make significant contributions to the field. With two patents, including his groundbreaking work on the sacubitril intermediate and its preparation method, Chen has proven himself as an inventive and capable researcher. His dedication to improving the pharmaceutical industry, along with his collaborations with esteemed colleagues like Guodong Sun and Xiaodong Han, highlights his commitment to innovation. Lei Chen's impressive achievements underscore his immense potential for future breakthroughs and his status as a valuable asset in the world of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile